Navigation Links
A prognosis for GE and Abbott Diagnostics

What is more important: diagnostics, therapeutics, or prognosis? While all are important, we will in this column see how past history has addressed this question and also how recent events, such as GE's acquisition of Abbott's diagnostics units, shed light on this fundamental issue.

It is al......

Full article >>> t centers.

While his emphasis on treatment facilities was simply an oversight, a radiologist friend of mine couldn't help but cheekily point out whether it meant that diagnostic centers were to be left as open targets. While we were not often in a joking mood during those days, it did point out how deeply ingrained our focus on treatment has become.

While diagnosis plays second f......

Full article >>> such as its pharmaceuticals and devices - are marketed mostly through physicians and direct-to-consumer channels.

GE has a significant marketing advantage and experience when it comes to big-box purchases. Moreover, the GE commercial finance arm also facilitates the ability to purchase these big boxes through leasing or other arrangements. The same marketing strength can also be applied t......

Full article >>> t means that radiologic diagnoses can be done at the bedside with a portable scanner, in the CT/MRI suite or in the ER, as opposed to getting your results later that evening. If you can do that with a huge, multimillion-dollar MRI machine, why can't you do that with a simple blood test?

Indeed, that is the premise behind Abbott's point-of-care system. This is how the cultural paradigm tha......

Full article >>> ts.jsp?release_id=12212">press release does not usually count as high-end literary criticism, reading more deeply reveals some important messages.

In this regard, Abbott may be considering its in-vitro and point-of-care businesses as commodities compared to its molecular business. Without the infusion of GE's hospital-based marketing focus, GE's advanced radiologic technology and GE's......

Full article >>> live, and how well they will live. To answer the question posed at the beginning of this column, most people will agree that in this context, prognosis ranks first.

Abbott is betting on the supremacy of prognosis. While the GE acquisition makes excellent business sense for GE, the future lies with those companies that can accurately, relevantly, and usefully bring prognostic information ......

Full article >>> . He can be e-mailed at ogan@midwestbusiness.com.

This article previously appeared in MidwestBusiness.com, and was reprinted with its permission.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of ......

Full article >>>
'"/>

Source:wistechnology.com By Ogan Gurel 02/05/07


Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. Wisconsin court halts Abbotts sale of genotyping products
3. Wisconsin court affirms damages in Innogenetics, Abbott patent case
4. Abbott Labs campus in Kenosha could send ripples through local biotech
5. Abbott Executive Jim Tyree Takes IBIO Helm
6. Promega Announces Agreement with Abbott
7. Roche Diagnostics Corporation
8. Roche Diagnostics Corporation
9. BioDiagnostics is first seed-testing lab to gain new accreditation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... PARK, Calif. , Dec. 6, 2016 /PRNewswire/ ... up to $150 million from the National Institutes ... Diseases and the Division of AIDS (NIAID-DAIDS) to ... and other non-vaccine pre-exposure (PreP) agents. Under the ... of preclinical product development services for candidate HIV-prevention ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... discovery and development of precision treatments for neurodegenerative diseases, today announced the ... (AD) inhibited the direct neurotoxic effect of prion-like forms of Amyloid beta ...
(Date:12/5/2016)... , Dec. 5, 2016 Axovant Sciences Ltd. ... company focused on the treatment of dementia, today announced ... the treatment of Alzheimer,s disease will be presented at ... on Friday, December 9, 2016 in San ... results of both simple and complex measures of activities ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... "Biomarkers - Technologies, Markets and Companies" to their offering. ... , , ... and their discovery using various -omics technologies such as proteomics and ... and new tests are also based on biomarker. Currently ...
Breaking Biology Technology:
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
Breaking Biology News(10 mins):